Average Co-Inventor Count = 5.59
ph-index = 15
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (18 from 3,684 patents)
2. Innate Pharma (4 from 66 patents)
3. Medimmune Limited (1 from 541 patents)
19 patents:
1. 12209126 - Treatment of cancer
2. 10688180 - Combination of anti-KIR and anti-CTLA-4 antibodies to treat cancer
3. 10604575 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
4. 10584170 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
5. 10577423 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
6. 10494433 - Combination of anti-KIR and anti-CS1 antibodies to treat multiple myeloma
7. 10323093 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
8. 10323092 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
9. 10316090 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
10. 10316091 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
11. 10308714 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
12. 10266594 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
13. 10266595 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
14. 10266596 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling
15. 10138299 - Cancer immunotherapy by disrupting PD-1/PD-L1 signaling